​Opening date​â¶Ä‹: 6 June 2025
Closing date and time: 11:59pm AEST on 14 July 2025
Project delivery timeframe (for successful applications): 1 July 2026–30 June 2030
Decision-maker: PRSP Selection Panel
ºÚÁϳԹÏÍø Government Agency: ºÚÁϳԹÏÍø Ministry of Health
Grant value (total available funding for the grant and the available individual grant amounts, excluding GST): Total of $12 million (excluding GST) with $4 million (excluding GST) available to each of the three priority research streams over 4 years.
Enquiries: moh-prsp@health.nsw.gov.au
​The Prevention Research Support Program (PRSP) is a competitive funding program of the ºÚÁϳԹÏÍø Ministry of Health. To date there have been six rounds of funding under the Program. Round 7 of the PRSP will run from 1 July 2026 to 30 June 2030.​​​
The PRSP invests in research in prevention priority areas which drive system and community outcomes in ºÚÁϳԹÏÍø. The PRSP also aims to build on and extend prevention research capability in ºÚÁϳԹÏÍø.
For Round 7 three priority research streams have been identified:
​The PRSP is funded by the ºÚÁϳԹÏÍø Ministry of Health and administered by the Centre for Epidemiology and Evidence, Population and Public Health Division.
The purpose of Round 7 of the PRSP is to fund the co-production of research, and facilitate its timely application to policy and practice, across the three priority research streams. Recognising that the scope of research under each stream is broad and complex, collaboration between research groups via the formation of consortia is strongly encouraged. To comprehensively address the scope of work required under the relevant priority research stream, each consortium should:
The objectives of Round 7 of the PRSP are to:
PRSP funding may be directed towards:​​
Applications are only eligible for consideration for Round 7 of the PRSP if they submit a complete Expression of Interest form, and meet all the following criteria:​​
The lead investigator must be employed by the administering organisation. ​​â¶Ä‹â€‹â€‹
One of the aims of this funding stream is to build on and extend prevention research capability in ºÚÁϳԹÏÍø. All the grant funding awarded must be allocated to ºÚÁϳԹÏÍø-based institutions and staff. Consortia can include investigators from other jurisdictions if required, however, they cannot receive funds from the grant.
All team members and investigators must have the right to work in Australia through being an Australian citizen, a permanent resident of Australia, or having an appropriate working visa for the full term of the grant.
We expect all funding recipients to be employed by not-for-profit organisations, Universities, or government agencies (e.g. local health districts)​. If there are any specific instances where this is not the case, this will need to be discussed with the Ministry for each specific purpose and on a case-by-case basis. ​​
Below are the assessment criteria that will be used to determine which EOIs proceed to the next phase of the assessment process. As no single ºÚÁϳԹÏÍø research institution likely excels across all focus areas of the priority streams, ºÚÁϳԹÏÍø Health will view favourably collaborations that leverage the state's best collective expertise.​
50%​â¶Ä‹
Please detail your teams’ research capability relevant to the stream you are applying to.
20%
10%
The consortium will appoint one lead organisation, which will be responsible for administration and funding, and participate in the co-design of partnership and governance structures with ºÚÁϳԹÏÍø Ministry of Health.
The EOI process will open on 6 June 2025 and close on 14 July 2025 at 11:59pm AEST. ​â¶Ä‹
​EOI forms​ are to be submitted via email to the Centre for Epidemiology and Evidence at moh-prsp@health.nsw.gov.au.
All applications will receive an email to acknowledge receipt within 72 business hours. It is the applicant’s responsibility to follow up if no acknowledgement email is received.
The maximum email size is 20MB. Larger emails will be rejected by the ºÚÁϳԹÏÍø Health server, and you may not be notified that the email has been rejected.
Applicants are not required to submit a detailed work plan or budget template as part of the EOI form. The focus is on applicants demonstrating:
Answers to frequently asked questions and updates on Round 7 of the PRSP can be found on the main PRSP page.​
Please direct any questions regarding Round 7 of the PRSP to moh-prsp@health.nsw.gov.au​. ​
Following the submission of EOIs, ºÚÁϳԹÏÍø Health will determine if each EOI has satisfied the eligibility criteria. Applicants must meet all eligibility criteria to proceed to Step 2. Eligibility checks will be undertaken by ºÚÁϳԹÏÍø Ministry of Health staff, who may contact applicants directly to clarify any issues with their EOI.​
The selection panel will assess each eligible EOI on their merits against the assessment criteria. This may also include:
Following assessment of the EOIs, selected applicants will be invited to present to the selection panel and participate in an interview.
Further information about this step will be made available to applicants progressing to this stage of the application process.​
The selection panel will agree on the final ranking of all eligible applications and determine grant recipients and amounts.
In August–​September 2025, the preferred consortium for each priority research stream will be notified and will be invited for initial meetings with relevant policy teams and other key ºÚÁϳԹÏÍø Health stakeholders to determine a research plan for the coming year and associated key deliverables. This may also include developing governance structures and terms of reference.
It is anticipated grant agreements will be signed between ºÚÁϳԹÏÍø Health and each successful administering organisation in October–​​November 2025, following co​-development of a workplan.
Successful recipients of the PRSP will be published on the PRSP website and on the ºÚÁϳԹÏÍø Government Grants and Funding Finder in accordance with ºÚÁϳԹÏÍø Government requirements. ​â¶Ä‹â€‹
The funding for Round 7 of the PRSP commences 1 July 2026. Detail will be provided in the grant agreement. Anticipated key terms and conditions for applicants to be aware of include:
Funds will be paid quarterly following an invoice sent to the ºÚÁϳԹÏÍø Ministry of Health by the administering organisations.
The administering organisation may:
A schedule for financial reporting will be outlined in the funding agreement and will include a requirement to provide:
If the parties cannot agree on an issue of a notified dispute within 20 business days, then the dispute is referred to the Dispute Resolution Officer. The Dispute Resolution Officer is:​
Position: Chief Health Officer and Deputy Secretary Population and Public Health, ºÚÁϳԹÏÍø Ministry of Health
Name: Dr Kerry Chant PSM
Address: Level 9, 1 Reserve Road, St Leonards ºÚÁϳԹÏÍø 2065
The GIPA Act provides for the proactive release of government information by agencies and gives members of the public an enforceable right to access government information held by an agency (which includes Ministerial offices). Access to government information is only to be restricted if there is an overriding public interest against disclosure.
The ºÚÁϳԹÏÍø Legislative Council has the power to order the production of State papers by the Executive Government. Standing Order 52 provides that the House may order documents to be tabled by the Government in the House. The Cabinet Office coordinates the preparation of the papers – that is, the return to order. The return to order may contain privileged and public documents. Privileged documents are available only to members of the Legislative Council.
Note that documents submitted as part of a grant application may be subject to an application under the GIPA Act or an order for papers under Standing Order 52.
Provide any relevant contact details or other sources of information for individuals seeking information from the relevant agency about the GIPA Act and/or Standing Order 52.